The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice.

about

The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice.

Item

http://www.wikidata.org/entity/Q24794251

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

The Myocardial Ischemia Reduct ...... ime to change current practice

@nl

The Myocardial Ischemia Reduct ...... me to change current practice.

@ast

The Myocardial Ischemia Reduct ...... me to change current practice.

@en

type

Item

label

The Myocardial Ischemia Reduct ...... ime to change current practice

@nl

The Myocardial Ischemia Reduct ...... me to change current practice.

@ast

The Myocardial Ischemia Reduct ...... me to change current practice.

@en

altLabel

The Myocardial Ischemia Reduct ...... ime to change current practice

@en

prefLabel

The Myocardial Ischemia Reduct ...... ime to change current practice

@nl

The Myocardial Ischemia Reduct ...... me to change current practice.

@ast

The Myocardial Ischemia Reduct ...... me to change current practice.

@en

P1476

The Myocardial Ischemia Reduct ...... me to change current practice.

@en

P2093

Herbert D Aronow

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.

Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality.

Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes.

P2888

1468-6708-3-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1186/1468-6708-3-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11383710

http://www.w3.org/2001/XMLSchema#string

P6179

1050309920

http://www.w3.org/2001/XMLSchema#string

P698

11985777

http://www.w3.org/2001/XMLSchema#string

P932

134475

http://www.w3.org/2001/XMLSchema#string